HIV/AIDS
Forecast Insight: HIV - Increasing Dominance of Fixed Dose Combinations Raises Bar for Single Agents
Published in AIDS Weekly, August 30th, 2010
In 2009, HIV antiretroviral sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations will ensure market growth until 2015, Datamonitor expects major patent expires and rising pressure to reduce healthcare costs to trigger a decline in HIV sales in the second half of the forecast period until 2019.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-08-30)
More Articles from AIDS Weekly
- HIV/AIDS
Data on HIV/AIDS reported by researchers at Institut des Sciences - HIV/AIDS
Findings from A.M. Elaiw and co-researchers advance knowledge in HIV/AIDS - HIV/AIDS
New HIV/AIDS research from Novartis outlined - HIV/AIDS
New HIV/AIDS study findings have been reported by researchers at National Cancer Institute - HIV/AIDS
New findings from R. Domenech and co-researchers in the area of HIV/AIDS described - Immunoglobulins
New immunoglobulins research reported from University of Edinburgh - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
